Disability

Large Clinical Study Finds Home-based Virtual Reality Treatment of Chronic Low Back Pain Clinically Effective Across Key Socio-demographics FactorsLarge Clinical Study Finds Home-based Virtual Reality Treatment of Chronic Low Back Pain Clinically Effective Across Key Socio-demographics Factors

Large Clinical Study Finds Home-based Virtual Reality Treatment of Chronic Low Back Pain Clinically Effective Across Key Socio-demographics Factors

Analysis of a randomized, placebo-controlled study of 1,000+ participants indicates socio-demographics are not a factor impacting clinically meaningful reductions in…

11 months ago
Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead CandidateOsteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate

Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate

Financing led by Zimmer Biomet with participation from existing investors Johnson & Johnson Innovation – JJDC, Inc., Gideon Strategic Partners,…

11 months ago
CirrusMD Completes National Roll-out of VA Health Chat, Providing Care Access for over 6.8 Million VeteransCirrusMD Completes National Roll-out of VA Health Chat, Providing Care Access for over 6.8 Million Veterans

CirrusMD Completes National Roll-out of VA Health Chat, Providing Care Access for over 6.8 Million Veterans

VA Health Chat is now available to Veterans in all 18 VISNs across the U.S.DENVER, June 05, 2024 (GLOBE NEWSWIRE)…

11 months ago
Cohere Health, Medical Mutual, and Rhyme Partner on Utilization Management TransformationCohere Health, Medical Mutual, and Rhyme Partner on Utilization Management Transformation

Cohere Health, Medical Mutual, and Rhyme Partner on Utilization Management Transformation

Intelligent prior authorization enables faster access to care and higher quality outcomes for members while enhancing provider experience and improving…

11 months ago
Nalu PNS System Achieves Significant and Durable Pain Reduction, Meeting the Primary Endpoint of the COMFORT RCT StudyNalu PNS System Achieves Significant and Durable Pain Reduction, Meeting the Primary Endpoint of the COMFORT RCT Study

Nalu PNS System Achieves Significant and Durable Pain Reduction, Meeting the Primary Endpoint of the COMFORT RCT Study

CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical Inc. (“Nalu”) revealed significant findings from a landmark clinical trial evaluating the Nalu Peripheral Nerve Stimulation…

11 months ago
Theralase(R) Release’s 1Q2024 Financial StatementsTheralase(R) Release’s 1Q2024 Financial Statements

Theralase(R) Release’s 1Q2024 Financial Statements

TORONTO, ON / ACCESSWIRE / May 30, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ")…

11 months ago
AIDPH Provides Written Testimony on Senate Committee Dental Crisis HearingAIDPH Provides Written Testimony on Senate Committee Dental Crisis Hearing

AIDPH Provides Written Testimony on Senate Committee Dental Crisis Hearing

Testimony Offers Policy Solutions for Veterans, People with Disabilities, LGBTQIA+ People, and Rural CommunitiesWASHINGTON, DC / ACCESSWIRE / May 29,…

11 months ago
Assured Allies Announces a Multi-Year Partnership to Support CalPERS Long-Term Care Policyholders in Maintaining Their IndependenceAssured Allies Announces a Multi-Year Partnership to Support CalPERS Long-Term Care Policyholders in Maintaining Their Independence

Assured Allies Announces a Multi-Year Partnership to Support CalPERS Long-Term Care Policyholders in Maintaining Their Independence

Assured Allies will provide the AgeAssured program to over 45,000 CalPERS policyholders for a period of at least 5 yearsAgeAssured…

11 months ago
IRLAB has Administered the First Dose in a Phase I Clinical Trial with the Drug Candidate IRL757IRLAB has Administered the First Dose in a Phase I Clinical Trial with the Drug Candidate IRL757

IRLAB has Administered the First Dose in a Phase I Clinical Trial with the Drug Candidate IRL757

GOTHENBURG, SWEDEN / ACCESSWIRE / May 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 22, 2024 - IRLAB Therapeutics…

11 months ago